Vinay Bharadwaj Tatipamula

Dr. Vinay Bharadwaj Tatipamula

Duy Tan University, Da Nang 550000, Vietnam
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

29 September 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HNHa Thi Nguyen
Ha Thi Nguyen
TVThien-Y. Vu
Thien-Y. Vu
VCVishala Chandi
Vishala Chandi
HPHaritha Polimati
Haritha Polimati
VTVinay Bharadwaj Tatipamula
Vinay Bharadwaj Tatipamula
Natural metabolites with their specific bioactivities are being considered as a potential source of materials for pharmacological studies. In this study, we successfully isolated and identified five known clerodane diterpenes, namely 16-oxo-cleroda-3,13(14)E-dien-15-oic acid (1), 16-hydroxy-cleroda-3,13-dien-15-oic acid (2), 16-hydroxy-cleroda-4(18),13-dien-16,15-olide (3), 3α,16α-dihydroxy-cleroda-4(18),13(14)Z-dien-15,16-olide (4), and 16α-hydroxy-cleroda-3,13(14)Z-dien-15,16-olide (5) from the methanolic extract of seeds of Polyalthia longifolia. Initially, all the isolated metabolites were investigated for COX-1, COX-2, and 5-LOX inhibitory activities using the standard inhibitory kits. Of which, compounds 3, 4, and 5 exhibited to be potent COX-1, COX-2, and 5-LOX inhibitors with the IC50 values similar or lower to those of the reference drugs. To understand the underlying mechanism, these compounds were subjected to molecular docking on COX-1, COX-2, and 5-LOX proteins. Interestingly, the in silico study results were in high accordance with in vitro studies where compounds 3, 4, and 5 hits assumed interactions and binding pattern comparable to that of reference drugs (indomethacin and diclofenac), as a co-crystallized ligand explaining their remarkable dual (COX/LOX) inhibitor actions. Taken together, our findings demonstrated that compounds 3, 4, and 5 functioned as dual inhibitors of COX/5-LOX and can contribute to the development of novel, more effective anti-inflammatory drugs with minimal side-effects.

1 January 2014 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
PSPrakasham Reddy Shetty
Prakasham Reddy Shetty
SBSudheer Kumar Buddana
Sudheer Kumar Buddana
VTVinay Bharadwaj Tatipamula
Vinay Bharadwaj Tatipamula
YNYaswanth Varanasi Venkata Naga
Yaswanth Varanasi Venkata Naga
JAJamal Ahmad
Jamal Ahmad
A highly potent secondary metabolite producing actinomycetes strain is isolated from marine soil sediments of Visakhapatnam sea coast, Bay of Bengal. Over all ten strains are isolated from the collected soil sediments. Among the ten actinomycetes strains the broad spectrum strain RSPSN2 was selected for molecular characterization, antibiotic production and its purification. The nucleotide sequence of the 1 rRNA gene (1261 base pairs) of the most potent strain evidenced a 96% similarity with Streptomyces parvulus 1044 strain, Streptomyces parvulus NBRC 13193 and Streptomyces parvulus BY-F. From the taxonomic features, the actinomycetes isolate RSPSN2 matches with Streptomyces parvulus in the morphological, physiological and biochemical characters. Thus, it was given the suggested name Streptomyces parvulus RSPSN2. The active metabolite was extracted using ethyl acetate (1:3, v/v) at pH 7.0. The separation of active ingredient and its purification was performed by using both thin layer chromatography (TLC) and column chromatography (CC) techniques. Spectrometric studies such as UV-visible, FTIR, and NMR and mass were performed. The antibacterial activity of pure compound was performed by cup plate method against some pathogenic bacteria including of streptomycin resistant bacteria like (Pseudomonas mirabilis, Pseudomonas putida and Bacillus cereus). In conclusion, the collected data emphasized the fact that a polypeptide antibiotic (Actinomycin D) was produced by Streptomyces parvulus RSPSN2.

2 April 2021 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
ASAnil Shrestha
Anil Shrestha
HNHuy Thuan Nguyen
Huy Thuan Nguyen
VTVinay Bharadwaj Tatipamula
Vinay Bharadwaj Tatipamula
DCDuong Van Cuong
Duong Van Cuong
NCNguyen Xuan Canh
Nguyen Xuan Canh
Dipesh DhakalDipesh Dhakal
Dipesh Dhakal

19 April 2022 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
HNHuy Thuan Nguyen
Huy Thuan Nguyen
VTVinay Bharadwaj Tatipamula
Vinay Bharadwaj Tatipamula
NCNguyen Xuan Canh
Nguyen Xuan Canh
NGNguyen Van Giang
Nguyen Van Giang

24 September 2021 in Biology
Verified
Journal Article
Open access
PDF file
BNBA THONG NGUYEN
BA THONG NGUYEN
DDDuy Ngoc Do
Duy Ngoc Do
Tung Nguyen-ThanhTung Nguyen-Thanh
Tung Nguyen-Thanh
VTVinay Bharadwaj Tatipamula
Vinay Bharadwaj Tatipamula
HNHa Thi Nguyen
Ha Thi Nguyen
Liver cancer is one of the most common cancers and the top leading cause of cancer death globally. However, the molecular mechanisms of liver tumorigenesis and progression remain unclear. In the current study, we investigated the hub genes and the potential molecular pathways through which these genes contribute to liver cancer onset and development. The weighted gene co-expression network analysis (WCGNA) was performed on the main data attained from the GEO (Gene Expression Omnibus) database. The Cancer Genome Atlas (TCGA) dataset was used to evaluate the association between prognosis and these hub genes. The expression of genes from the black module was found to be significantly related to liver cancer. Based on the results of protein–protein interaction, gene co-expression network, and survival analyses, DNA topoisomerase II alpha (TOP2A), ribonucleotide reductase regulatory subunit M2 (RRM2), never in mitosis-related kinase 2 (NEK2), cyclin-dependent kinase 1 (CDK1), and cyclin B1 (CCNB1) were identified as the hub genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses showed that the differentially expressed genes (DEGs) were enriched in the immune-associated pathways. These hub genes were further screened and validated using statistical and functional analyses. Additionally, the TOP2A, RRM2, NEK2, CDK1, and CCNB1 proteins were overexpressed in tumor liver tissues as compared to normal liver tissues according to the Human Protein Atlas database and previous studies. Our results suggest the potential use of TOP2A, RRM2, NEK2, CDK1, and CCNB1 as prognostic biomarkers in liver cancer.